SCHEMBL3767151

SCHEMBL3767151

Nc1ccccc1-c1ccc(Cl)cc1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
HSD11B1 P28845 2/20 0.46
GRM2 Q14416 2/20 0.46
ALOX5AP P20292 2/20 0.42
FEN1 P39748 2/20 0.42
PDE3B Q13370 1/20 0.42
PDE3A Q14432 1/20 0.42
S100A4 P26447 1/20 0.41
TSHR P16473 3/20 0.40
CYP3A4 P08684 2/20 0.40
ALOX15 P16050 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
GPR3 P46089 1/20 0.40
DPP4 P27487 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TP53 P04637 1/20 0.39
EGLN2 Q96KS0 1/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16121126 0.85 HSD11B1 (0.50) ALDH1A1HSD11B1S100A4TSHRCYP3A4
SCHEMBL20898069 0.84 HSD11B1 (0.51) HSD11B1GRM2S100A4GPR3DPP4
SCHEMBL31067088 0.84 HSD11B1 (0.51) HSD11B1GRM2S100A4GPR3DPP4
SCHEMBL23638850 0.81 S100A4 (0.46) HSD11B1GRM2S100A4GPR3TP53
SCHEMBL30598347 0.81 S100A4 (0.46) HSD11B1GRM2S100A4GPR3TP53
SCHEMBL397076 0.80 ALDH1A1 (0.54) ALDH1A1L3MBTL1HSD11B1S100A4TSHR
SCHEMBL3791385 0.80 ALDH1A1 (0.54) ALDH1A1L3MBTL1ALOX5APFEN1PDE3B
SCHEMBL399629 0.80 ALDH1A1 (0.54) ALDH1A1L3MBTL1ALOX5APFEN1PDE3B
SCHEMBL17868056 0.77 ALDH1A1 (0.48) ALDH1A1GRM2TSHRCYP3A4ALOX15
SCHEMBL23569917 0.77 HSD11B1 (0.49) ALDH1A1HSD11B1GRM2ALOX5APFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7847108-B2 such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms BAYER CROPSCIENCE AG (DE) 2010-12-07 US disclosed
US-7847108-B2 such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms BAYER CROPSCIENCE AG (DE) 2010-12-07 US disclosed
US-7847108-B2 such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms BAYER CROPSCIENCE AG (DE) 2010-12-07 US disclosed
EP-1509513-B1 MICROBICIDAL OXATHIINCARBOXAMIDES BAYER CROPSCIENCE AG (DE) 2009-07-29 EP disclosed
EP-1509513-B1 MICROBICIDAL OXATHIINCARBOXAMIDES BAYER CROPSCIENCE AG (DE) 2009-07-29 EP disclosed
EP-1513824-B1 FURANCARBOXAMIDES BAYER CROPSCIENCE AG (DE) 2008-10-01 EP disclosed
EP-1513824-B1 FURANCARBOXAMIDES BAYER CROPSCIENCE AG (DE) 2008-10-01 EP disclosed
US-20080171774-A1 Nicotinanilides, Method for Production Thereof and Agents Comprising the Same for Prevention of Fungal Pests BASF AKITENGESELLSCHAFT (DE) 2008-07-17 US disclosed
EP-1861369-A1 NICOTINANILIDES METHOD FOR PRODUCTION THEREOF AND AGENTS COMPRISING THE SAME FOR PREVENTION OF FUNGAL PESTS BASF AKTIENGESELLSCHAFT (DE) 2007-12-05 EP disclosed
EP-1599460-B1 OXATHIIN CARBOXAMIDE BAYER CROPSCIENCE AG (DE) 2007-11-07 EP disclosed
US-20070004793-A1 such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms BAYER INTELLECTUAL PROPERTY GMBH (DE) 2007-01-04 US disclosed
US-20070004793-A1 such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms BAYER INTELLECTUAL PROPERTY GMBH (DE) 2007-01-04 US disclosed
US-7119049-B2 Oxathiinecarboxamides BAYER CROPSCIENCE AG (DE) 2006-10-10 US disclosed
WO-2006097490-A1 NICOTINANILIDES METHOD FOR PRODUCTION THEREOF AND AGENTS COMPRISING THE SAME FOR PREVENTION OF FUNGAL PESTS BASF AKTIENGESELLSCHAFT (DE) 2006-09-21 WO disclosed
US-20060142381-A1 Furancarboxamides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2006-06-29 US disclosed
EP-1599460-A2 OXATHIIN CARBOXAMIDE Bayer CropScience Aktiengesellschaft (DE) 2005-11-30 EP disclosed
US-20050203171-A1 Oxathiincarboxamides BAYER CROPSCIENCE AG (DE) 2005-09-15 US disclosed
EP-1509513-A1 OXATHIINCARBOXAMIDES Bayer CropScience AG (DE) 2005-03-02 EP disclosed
WO-2004072023-A2 OXATHIIN CARBOXAMIDE BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2004-08-26 WO disclosed
WO-2003099804-A1 OXATHIINCARBOXAMIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2003-12-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050203171-A1 Oxathiincarboxamides MRPL21, ODC1, DDT ALDH1A1 138/4885L3MBTL1 719/4885HSD11B1 4152/4885
US-20080171774-A1 Nicotinanilides, Method for Production Thereof and Agents Comprising the Same for Prevention of Fungal Pests CBR3, CBR1, NNMT ALDH1A1 3334/4885L3MBTL1 1097/4885HSD11B1 2623/4885
US-20060142381-A1 Furancarboxamides DDT, MRM1, FPR1 ALDH1A1 225/4885L3MBTL1 2891/4885HSD11B1 3793/4885
US-20070004793-A1 such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms Q6ZSR9, PFAS, NIT2 ALDH1A1 1804/4885L3MBTL1 174/4885HSD11B1 4401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.